Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. (SDMHF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
sdmhf · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Hold
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $206.01
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $212.88 | ↑ 3.34% |
1-day model range: $211.93–$213.83. Peak: $213.83 (+3.34%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $220 | +6.7% |
| 2028 | $229 | +11.4% |
| 2029 | $236 | +14.5% |
| 2030 | $240 | +16.6% |
| 2031 | — | +18.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SDMHF · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-10-01 | Societe Generale | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Sartorius Stedim Biotech S.A. (SDMHF) stock. Of the recent 1 rating actions, 0 were upgrades and 1 were downgrades. 1 analysts currently cover SDMHF.
Analyst Recommendation Trends
SDMHF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3.2B
↓ 18.4% YoY
Revenue Next Year
$3.5B
↑ 10.5% YoY
EPS This Year
$5.14
EPS Next Year
$6.10
↑ 18.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast SDMHF EPS of $5.14 for the current fiscal year, based on estimates from 1 analysts. The SDMHF revenue forecast is $3.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SDMHF stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SDMHF price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The SDMHF short-term stock prediction for tomorrow is $212.88 (+3.34%). The SDMHF stock price prediction for 2027 estimates an average of $220. The SDMHF stock prediction for 2030 projects a range of $229–$252.
Sartorius Stedim Biotech S.A. trades on OTC under the ticker SDMHF. The SDMHF stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
SDMHF forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month SDMHF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $206.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.